CERTOLIZUMAB PEGOL RA Adverse Event: Interstitial lung disease
CERTOLIZUMAB PEGOL RA Adverse Event: Interstitial lung disease is one of 4,500 adverse events in the FDATracker dataset. Key details — Primary drug: CERTOLIZUMAB PEGOL RA; Product category: Drug; Primary reaction: Interstitial lung disease.
| Primary drug | CERTOLIZUMAB PEGOL RA |
|---|---|
| Product category | Drug |
| Primary reaction | Interstitial lung disease |
| All reactions | Interstitial lung disease; Nasopharyngitis |
| Seriousness | Serious |
| Patient outcome | Recovered/Resolved |
| Patient sex | Female |
| All drugs reported | CERTOLIZUMAB PEGOL RA; PREDNISOLONE.; PREDNISOLONE.; CERTOLIZUMAB PEGOL RA |
| Reporter country | JP |
| Reporter type | 1 |
| Report date | 20140313 |
| Report ID | 10005938 |
$299/mo
Try FDATracker →